FDA Drug Application (205831) for APTENSIO XR by RHODES PHARMS

Back to FDA Applications sponsored by RHODES PHARMS

Application Number205831
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage10MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameAPTENSIO XR
Active IngredientMETHYLPHENIDATE HYDROCHLORIDE



Back to FDA Applications sponsored by RHODES PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.